Related Experiment Video
Updated: Jan 16, 2026
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
Targeting cell cycle checkpoints for glioma therapy
Fengchao Lang1, Chunzhang Yang1
1Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, MD 20892, USA.
Abstract:
Glioma is a devastating disease associated with unfavorable clinical outcomes. Current standard treatments, including surgery, radiotherapy, and chemotherapy, are largely palliative and offer limited improvements in survival rates. Glioma is characterized by high proliferative capacity, which is primarily through exploiting the dysregulated cell cycle mechanisms for disease progression. Over the past few decades, targeting the glioma cell cycle-particularly key molecules involved in cell cycle checkpoints-has been a promising direction for future glioma therapeutics. In this review, we summarize the distinctive molecular patterns of cell cycle in glioma, and discuss emerging targeted therapies designed for glioma cell cycle regulators.
Insights
Glioma treatment is limited, but targeting the cell cycle offers promise. This review details glioma cell cycle patterns and emerging therapies for this devastating brain tumor.
Area of Science:
- Neuro-oncology
- Cancer biology
- Molecular medicine
Background:
- Glioma is an aggressive brain tumor with poor prognosis.
- Current treatments like surgery, radiation, and chemotherapy provide limited survival benefits.
- Glioma's rapid proliferation is driven by dysregulated cell cycle mechanisms.
Purpose of the Study:
- To review the unique cell cycle molecular patterns in glioma.
- To discuss novel targeted therapies focused on glioma cell cycle regulators.
Main Methods:
- Literature review of glioma cell cycle mechanisms.
- Analysis of emerging targeted therapeutic strategies.
Main Results:
- Distinct molecular alterations in the cell cycle are characteristic of glioma.
- Targeting cell cycle checkpoints presents a promising therapeutic avenue.
Conclusions:
- Understanding glioma cell cycle dysregulation is crucial for developing effective treatments.
- Targeted therapies offer potential for improved clinical outcomes in glioma patients.
More Related Videos
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
09:36Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Published on: August 29, 2018
Related Concept Videos
01:28The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
02:34Inhibition of Cdk Activity
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...